Delivery Order SPE2DB20D2014-SPE2DB25FC82V
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,592.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,138.88 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,584.22 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 8, 2025, with performance to be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open competition among qualified pharmaceutical distributors....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,956.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor...
- The Defense Logistics Agency awarded a $1,383.93 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 1, 2025, with completion expected by August 4, 2025. This firm fixed-price contract, issued without set-aside designation, leverages AmerisourceBergen's established relationship with DLA through competitive procurement procedures. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a ceiling value of $1,735.26. This firm fixed-price delivery order, which must be completed by August 11, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement. The contract carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,907.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 21, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract involves no set-aside designation and is issued as a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,514.37 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,868.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC82VDelivery Order
The Defense Logistics Agency (DLA) awarded a $3,121.72 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a completion date of August 26, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger vehicle, this delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of medications and medical supplies to military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The award demonstrates AmerisourceBergen's established capability as a critical pharmaceutical distributor within the federal medical supply chain, fulfilling orders across multiple therapeutic domains including specialty medications and brand-name drugs like Trulicity, a diabetes medication.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/25/25 |